Proteomics Characterization of the Cytotoxicity Mechanism of Ganoderic Acid D and Computer-automated Estimation of the Possible Drug Target Network*S

Triterpenes isolated from Ganoderma lucidum could inhibit the growth of numerous cancer cell lines and were thought to be the basis of the anticancer effects of G. lucidum. Ganoderic acid D (GAD) is one of the major components in Ganoderma triterpenes. GAD treatment for 48 h inhibited the proliferation of HeLa human cervical carcinoma cells with an IC50 value of 17.3 ± 0.3 μm. Flow cytometric analysis and DNA fragmentation analysis indicated that GAD induced G2/M cell cycle arrest and apoptosis. To identify the cellular targets of GAD, two-dimensional gel electrophoresis was performed, and proteins altered in expressional level after GAD exposure of cells were identified by MALDI-TOF MS/MS. The regulation of proteins was also confirmed by Western blotting. The cytotoxic effect of GAD was associated with regulated expression of 21 proteins. Furthermore these possible GAD target-related proteins were evaluated by an in silico drug target searching program, INVDOCK. The INVDOCK analysis results suggested that GAD could bind six isoforms of 14-3-3 protein family, annexin A5, and aminopeptidase B. The direct binding affinity of GAD toward 14-3-3 ζ was confirmed in vitro using surface plasmon resonance biosensor analysis. In addition, the intensive study of functional association among these 21 proteins revealed that 14 of them were closely related in the protein-protein interaction network. They had been found to either interact with each other directly or associate with each other via only one intermediate protein from previous protein-protein interaction experimental results. When the network was expanded to a further interaction outward, all 21 proteins could be included into one network. In this way, the possible network associated with GAD target-related proteins was constructed, and the possible contribution of these proteins to the cytotoxicity of GAD is discussed in this report.

[1]  X. Liu,et al.  Roles of p53, c-Myc, Bcl-2, Bax and caspases in glutamate-induced neuronal apoptosis and the possible neuroprotective mechanism of basic fibroblast growth factor. , 1999, Brain research. Molecular brain research.

[2]  K. Yamasaki,et al.  Structures of New Terpenoid Constituents of Ganoderma lucidum (Fr.) KARST (Polyporaceae) , 1985 .

[3]  R. Ravi,et al.  A nearly best-possible approximation algorithm for node-weighted Steiner trees , 1993, IPCO.

[4]  P. Chu,et al.  Keratin expression in human tissues and neoplasms , 2002, Histopathology.

[5]  N. Nakamura,et al.  Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. , 2000, Chemical & pharmaceutical bulletin.

[6]  M. Yaffe,et al.  Structural determinants of 14-3-3 binding specificities and regulation of subcellular localization of 14-3-3-ligand complexes: a comparison of the X-ray crystal structures of all human 14-3-3 isoforms. , 2006, Seminars in cancer biology.

[7]  Rui Li,et al.  Estrogen provides neuroprotection against activated microglia‐induced dopaminergic neuronal injury through both estrogen receptor‐α and estrogen receptor‐β in microglia , 2005 .

[8]  K. Yu Chen,et al.  Subcellular localization of the hypusine‐containing eukaryotic initiation factor 5A by immunofluorescent staining and green fluorescent protein tagging , 2002, Journal of cellular biochemistry.

[9]  D. Sliva,et al.  Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. , 2004, International journal of oncology.

[10]  M. H. Park,et al.  Hypusine is essential for eukaryotic cell proliferation. , 1993, Biological signals.

[11]  M. Marra,et al.  The role of eukaryotic initiation factor 5A in the control of cell proliferation and apoptosis , 2001, Amino Acids.

[12]  J. Turnay,et al.  Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5 , 2005, Journal of cellular biochemistry.

[13]  Fei Ye,et al.  The Dipeptide H‐Trp‐Glu‐OH Shows Highly Antagonistic Activity against PPARγ: Bioassay with Molecular Modeling Simulation , 2006, Chembiochem : a European journal of chemical biology.

[14]  T K Yun,et al.  Update from Asia: Asian Studies on Cancer Chemoprevention , 1999, Annals of the New York Academy of Sciences.

[15]  R. Zeng,et al.  Proteome analysis of hepatocellular carcinoma cell strains, MHCC97‐H and MHCC97‐L, with different metastasis potentials , 2004, Proteomics.

[16]  J. Hershey,et al.  Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae. , 1994, The Journal of biological chemistry.

[17]  K. Kashiwagi,et al.  Independent roles of eIF5A and polyamines in cell proliferation. , 2005, The Biochemical journal.

[18]  J. Yuen,et al.  Anticancer Effects of Ganoderma lucidum: A Review of Scientific Evidence , 2005, Nutrition and cancer.

[19]  Haojie Lu,et al.  Expressed proteome analysis of human hepatocellular carcinoma in nude mice (LCI‐D20) with high metastasis potential , 2006, Proteomics.

[20]  L. Kan,et al.  Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. , 2003, Life sciences.

[21]  H. Ng,et al.  Elevated cytokeratin-19 expression associated with apoptotic resistance and malignant progression of human cervical carcinoma , 2004, Apoptosis.

[22]  P. Stanton,et al.  Proteomic analysis of selected prognostic factors of breast cancer , 2004, Proteomics.

[23]  L. Pearl,et al.  Co-chaperone Regulation of Conformational Switching in the Hsp90 ATPase Cycle* , 2004, Journal of Biological Chemistry.

[24]  Hai-long Yang.  Ganoderic acid produced from submerged culture of Ganoderma lucidum induces cell cycle arrest and cytotoxicity in human hepatoma cell line BEL7402 , 2005, Biotechnology Letters.

[25]  E. Fey,et al.  Molecular characterization of mitofilin (HMP), a mitochondria-associated protein with predicted coiled coil and intermembrane space targeting domains. , 1996, Journal of cell science.

[26]  D. Guo,et al.  Quantitative determination of six major triterpenoids in Ganoderma lucidum and related species by high performance liquid chromatography. , 2006, Journal of pharmaceutical and biomedical analysis.

[27]  D. H. Kim,et al.  Calumenin, a multiple EF-hands Ca2+-binding protein, interacts with ryanodine receptor-1 in rabbit skeletal sarcoplasmic reticulum. , 2006, Biochemical and biophysical research communications.

[28]  A. Abbruzzese,et al.  Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation. , 2000, European journal of biochemistry.

[29]  D. Sliva,et al.  Cellular and physiological effects of Ganoderma lucidum (Reishi). , 2004, Mini reviews in medicinal chemistry.

[30]  C. Walczak,et al.  Mitotic spindle assembly and chromosome segregation: refocusing on microtubule dynamics. , 2004, Molecular cell.

[31]  N. Seeram,et al.  Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. , 2006, Leukemia research.

[32]  M. Park.  The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A). , 2006, Journal of biochemistry.

[33]  D. Guo,et al.  Two New Lanostanoid Triterpenes from the Fruit Body of Ganoderma lucidum-the Major Component of SunRecome® , 2006 .

[34]  Li Mao,et al.  Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry , 2004, Clinical & Experimental Metastasis.

[35]  Rebecca A Green,et al.  APC and EB1 function together in mitosis to regulate spindle dynamics and chromosome alignment. , 2005, Molecular biology of the cell.

[36]  J. Irazusta,et al.  Altered levels of acid, basic, and neutral peptidase activity and expression in human clear cell renal cell carcinoma. , 2007, American journal of physiology. Renal physiology.

[37]  H. Ng,et al.  Cytokeratin-19 associated with apoptosis and chemosensitivity in human cervical cancer cells , 2004, Apoptosis.

[38]  Yu Jin,et al.  Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. , 2004, Cancer letters.

[39]  M. Kanamori,et al.  Downregulation of EphA7 by hypermethylation in colorectal cancer , 2005, Oncogene.

[40]  M. Heatley,et al.  Keratin expression in human tissues and neoplasms , 2002, Histopathology.

[41]  Ganoderma lucidum.  Ganoderma lucidum in cancer research , 2006 .

[42]  Erich E. Wanker,et al.  UniHI: an entry gate to the human protein interactome , 2006, Nucleic Acids Res..

[43]  G. Powis,et al.  Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. , 2003, Molecular cancer research : MCR.

[44]  S. Moss,et al.  Annexins and disease. , 2004, Biochemical and biophysical research communications.

[45]  G. Tzivion,et al.  14-3-3 proteins as potential oncogenes. , 2006, Seminars in cancer biology.

[46]  C. Reutelingsperger,et al.  Cell Surface-expressed Phosphatidylserine and Annexin A5 Open a Novel Portal of Cell Entry* , 2004, Journal of Biological Chemistry.

[47]  K. Kang,et al.  Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF‐7 human breast cancer cell , 2002, International journal of cancer.

[48]  Y. Kimura,et al.  Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. , 2002, Anticancer research.

[49]  Sonia Grego,et al.  EB1-microtubule interactions in Xenopus egg extracts: role of EB1 in microtubule stabilization and mechanisms of targeting to microtubules. , 2002, Molecular biology of the cell.

[50]  R. Davis,et al.  Biomarkers of human cutaneous squamous cell carcinoma from tissues and cell lines identified by DNA microarrays and qRT-PCR. , 2003, Biochemical and biophysical research communications.

[51]  B. Bastian.  Annexins in cancer and autoimmune diseases , 1997, Cellular and Molecular Life Sciences CMLS.

[52]  S. Masters,et al.  14-3-3 Proteins Mediate an Essential Anti-apoptotic Signal* , 2001, The Journal of Biological Chemistry.

[53]  Y.Z. Chen,et al.  Ligand–protein inverse docking and its potential use in the computer search of protein targets of a small molecule , 2001, Proteins.

[54]  H. Christian,et al.  Expression, subcellular localization and phosphorylation status of annexins 1 and 5 in human pituitary adenomas and a growth hormone‐secreting carcinoma , 2004, Clinical endocrinology.

[55]  Jiahua Jiang,et al.  Ganoderma lucidum Suppresses Growth of Breast Cancer Cells Through the Inhibition of Akt/NF-κB Signaling , 2004, Nutrition and cancer.

[56]  H. Hermeking,et al.  14-3-3 proteins in cell cycle regulation. , 2006, Seminars in cancer biology.

[57]  Rui Li,et al.  Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia. , 2005, Journal of neuroscience research.

[58]  Li Du,et al.  Severe Acute Respiratory Syndrome Coronavirus 3C-like Proteinase N Terminus Is Indispensable for Proteolytic Activity but Not for Enzyme Dimerization , 2005, Journal of Biological Chemistry.